Related Experiment Video
Updated: Sep 26, 2026

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
Published on: April 2, 2021
Hyperglycemia and retinopathy of prematurity in very low birth weight infants
Ruchira Garg1, Alexander G Agthe, Pamela K Donohue
1Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21287-3200, USA.
Insights
High blood glucose levels in premature infants are linked to an increased risk of developing retinopathy of prematurity (ROP). This finding suggests glucose management may be crucial for preventing ROP in very low-birth-weight infants.
Area of Science:
- Neonatalogy
- Ophthalmology
- Pediatric Critical Care
Background:
- Retinopathy of prematurity (ROP) is a significant cause of vision impairment in premature infants.
- Very low-birth-weight (VLBW) infants are particularly susceptible to ROP.
Purpose of the Study:
- To investigate the association between serum/blood glucose levels and the development of ROP in VLBW infants.
- To identify potential risk factors for ROP in this vulnerable population.
Main Methods:
- A retrospective case-control study was conducted on VLBW infants (<1000 g) born between 1992 and 1997.
- Infants with Stage 3 or 4 ROP were compared to controls with Stage 1 ROP or no eye disease, matched for gestational age, birth weight, and year of birth.
- Odds ratios were calculated for exposures including glucose levels, oxygen concentration, vitamin E, and other clinical factors.
Main Results:
- Increased ROP risk was associated with higher mean glucose levels (OR 1.96-2.7 per 10 mg/dl increase).
- Higher oxygen concentration (FiO2) and history of dopamine infusion also increased ROP risk.
- Vitamin E supplementation showed a protective effect, reducing ROP risk (OR 0.37).
Conclusions:
- Glucose levels during the first month of life are associated with ROP development in VLBW infants.
- Further research is needed to confirm if this association is causal or if hyperglycemia reflects illness severity.
- Glucose monitoring and management may play a role in ROP prevention strategies.
Objective:
Retinopathy of prematurity (ROP) remains a leading cause of morbidity in the very low-birth-weight (VLBW) infant. This study investigates a possible association between serum/blood glucose and the development of ROP.
Methods:
A retrospective case-control study of all infants born between 1992 and 1997 at the Johns Hopkins Hospital with birth weights less than 1000 g who developed Stage 3 or 4 ROP was conducted. Controls either had Stage 1 ROP or no eye disease and were matched 2:1 with ROP patients for gestational age, birth weight and year of birth. Odds ratios (ORs) of ROP were calculated for multiple exposures over the first month after birth, including oxygen concentration (FiO(2)), blood glucose levels, vitamin E, mean airway pressure and mean blood pressure.
Results:
In a simple logistic regression analysis, we found an increased ROP risk for: (1) each 10 mg/dl increase of mean glucose (OR 1.96; 95% CI 1.13 to 3.42), (2) each 1% increase of mean FiO(2) (OR 1.06; 95% CI 1.004 to 1.13), (3) history of dopamine infusion (OR 5.4; 95% CI 1.16 to 25.2) and (4) intraventricular hemorrhage Grade 3 or 4 (OR 7.3; 95% CI 1.53 to 34.7). Using a multiple regression model, we found an increased ROP risk for each 10 mg/dl increase of mean glucose (OR 2.7; 95% CI 1.003 to 7.27). Each IU/kg/day of vitamin E supplementation reduced ROP risk (OR 0.37; 95% CI 0.16-0.86).
Conclusion:
In this study, we could demonstrate that glucose levels in the first month of life are associated with the development of ROP. Further studies have to determine if this association is causal or if hyperglycemia is just an expression of severity of illness.
Related Concept Videos
Diabetic Retinopathy
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational
Type I Diabetes III: Clinical Manifestations
Hypoglycemia
Hyperglycemia

